We're a small, talented and passionate team of professionals.

  • Ulf Nehrbass

    Chief Executive Officer

    A graduate of Cambridge University Ulf worked at the Rockefeller University, N.Y.C. and as Section Head of the Institut Pasteur, Paris, before moving into drug development as founder and CEO of Institut Pasteur Korea as well as QurlentTherapeutics.

    • Yong-Jun Kwon

      Head of Early Discovery and Technology Development

      PhD in Functional Genomics from Yonsei University, Seoul, Korea. 11 years of experience in translational research at the Institut Pasteur Korea and the Samsung Medical Center.  He is responsible for Ksilink’s high-content screening and technology development.

      • Mona Boyé

        Scouting and Bussiness Development

        Mona studied immunobiology in Constance, Germany and obtained her PhD degree in molecular biology from Cardiff Bioschool, UK.  After her postdoc she absolved a training about Intellectual Property at the TH Berlin, Germany.  

        • Antoine de Lacombe

          Chief Financial Officer

          Graduated from Université Paris-Dauphine in management and Institut d’Etudes Politiques de Paris in corporate finance. Antoine started with Ernst & Young Audit.  He then joined a privately-owned Investment fund where he gained experience in corporate finance and restructuring.

          • Peter Sommer

            R&D Portfolio Management and Competitive Intelligence

            PhD in Virology from the University of the Saarland. Peter has gathered 15 years of experience in translational research in Pasteur Institutes in Europe and Asia.

            • François Kien

              Administrative Coordinator

              PhD in Virology from the University of Strasbourg. François spent 9 years in the International Network of Institut Pasteur as scientist and PR officer.